Manchester Cancer Research Centre will continue its leadership in early detection science following the renewal of ACED
Manchester Cancer Research Centre shared a post on LinkedIn:
“We’re delighted Manchester will continue its leadership in early detection science following the successful renewal of ACED.
ACED is a £50m Alliance between Cancer Research UK, The University of Manchester, University College London, Knight Cancer Institute at OHSU, University of Cambridge, Dana-Farber Cancer Institute and the German Cancer Research Centre.
ACED will accelerate cutting-edge research in four major programmatic areas – immunology, hereditary cancers, inequalities, and interception as well as driving a bespoke ACED Training Programme to support the next generation of early detection researchers.
‘The next phase of the International Alliance for Cancer Early Detection offers an exciting opportunity to identify, detect and intercept cancer earlier for people across the world.’ – Prof. Robert Bristow, ACED Member Centre Director at Manchester.”
More posts featuring Manchester Cancer Research Centre.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023